---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-221331"
form_type: "8-K/A"
ticker: "BTMD"
cik: "0001819253"
company_name: "biote Corp."
filed_at: "2022-08-15T23:59:59+00:00"
generated_at: "2026-06-24T00:01:39.605657+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Biote corrects Q2 2022 net income down $9.4M; operating loss widened by $9.4M on omitted deal costs

## Summary
- Corrected Q2 2022 net income $40.3M (was $49.7M); operating loss $(85.6M) (was $(76.2M)).
- Six-month net income now $49.7M (was $59.1M); operating loss $(75.8M) (was $(66.4M)).
- Omitted $7.2M in excess fair value of shares and $2.2M consulting costs related to May 2022 business combination.
- Revenue of $47.5M and adjusted EBITDA of $13.1M for Q2 2022 were not impacted.
- Full-year 2022 guidance for revenue and adjusted EBITDA remains unchanged.

## SEC filing metadata
- accession: 0001193125-22-221331
- form_type: 8-K/A
- ticker: BTMD
- cik: 0001819253
- company_name: biote Corp.
- filed_at: 2022-08-15T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819253/000119312522221331/0001193125-22-221331-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819253/000119312522221331/d342876d8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-221331
- JSON: https://secwatch.observer/filing/0001193125-22-221331.json
- Plain text: https://secwatch.observer/filing/0001193125-22-221331.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.